Adverse events in second- and third-line treatments for acute and chronic graft-versus-host disease: systematic review:

2020 
Background:Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is associated with an increased risk of graft-versus-host disease (GvHD), a strong prognostic predictor of early mortality ...
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    61
    References
    2
    Citations
    NaN
    KQI
    []